SMS Pharma.

Market Cap: Small Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE812G01025
NSEID: SMSPHARMA
BSEID: 532815
View on NSE | View on BSE

INR

389.30

-2.15 (-0.55%)

BSENSE

Apr 02

BSE+NSE Vol: 4.01 lacs

{
  "main_header": {
    "sid": 517655,
    "name": "SMS Pharma.",
    "stock_name": "SMS Pharma.",
    "full_name": "SMS Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/sms-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "389.30",
    "chg": -2.15,
    "chgp": "-0.55%",
    "dir": -1,
    "prev_price": "391.45",
    "mcapval": "3,545.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 532815,
    "symbol": "SMSPHARMA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE812G01025",
    "curr_date": "Apr 02",
    "curr_time": "",
    "bse_nse_vol": "4.01 lacs",
    "exc_status": "Active",
    "traded_date": "Apr 02, 2026",
    "traded_date_str": "2026 04 02",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/sms-pharma-517655-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "SMS Pharmaceuticals Ltd Surges 7.38% to Day's High of Rs 389.8 — Outperforms Sector by 2.33 Percentage Points",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sms-pharmaceuticals-ltd-hits-intraday-high-with-738-surge-on-1-april-2026-3927794",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/SMSPharmaceutic_priceRelatedfactors_3927794.png",
        "date": "2026-04-01 09:31:50",
        "description": "The Sensex advanced 2.66% on 1 Apr 2026, yet SMS Pharmaceuticals Ltd outpaced the broader market with a 7.38% gain, reaching an intraday high of Rs 389.8. This 2.33 percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers signals a distinctly stock-specific momentum shift."
      },
      {
        "title": "SMS Pharmaceuticals Ltd is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sms-pharmaceuticals-ltd-is-rated-hold-by-marketsmojo-3922872",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SMSPharmaceutic_mojoScore_3922872.png",
        "date": "2026-03-29 10:10:02",
        "description": "SMS Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 01 September 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 March 2026, providing investors with an up-to-date perspective on the company’s performance and outlook."
      },
      {
        "title": "SMS Pharmaceuticals Gains 0.48%: 2 Key Factors Driving This Week’s Resilience",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sms-pharmaceuticals-gains-048-2-key-factors-driving-this-weeks-resilience-3922066",
        "imagepath": "",
        "date": "2026-03-28 15:08:38",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>23 Mar:</strong> Valuation shifts amid strong market performance</p>\n                    <p><strong>24 Mar:</strong> Intraday high with 7.82% surge</p>\n                    <p><strong>27 Mar:</strong> Week closes at Rs.386.55 (+0.48%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\">\n                        <div class=\"stat-label\">Week Open</div>\n                        <div class=\"stat-value\">Rs.384.70</div>\n                    </div>\n                    <div class=\"stat-item\">\n                        <div class=\"stat-label\">Week Close</div>\n                        <div class=\"stat-value\">Rs.386.55</div>\n               ..."
      },
      {
        "title": "SMS Pharmaceuticals Ltd Surges 7.82% to Day's High of Rs 397.3 — Outperforms Sector by 5.72 Percentage Points",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sms-pharmaceuticals-ltd-hits-intraday-high-with-782-surge-on-24-mar-2026-3910599",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SMSPharmaceutic_priceRelatedfactors_3910599.png",
        "date": "2026-03-24 13:30:52",
        "description": "The Sensex advanced 2.26% on 24 Mar 2026, yet SMS Pharmaceuticals Ltd outpaced the broader market with a robust 7.82% gain, touching an intraday high of Rs 397.3. This 5.72-percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers signals a distinctly stock-specific momentum shift."
      },
      {
        "title": "SMS Pharmaceuticals Ltd Valuation Shifts Amid Strong Market Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sms-pharmaceuticals-ltd-valuation-shifts-amid-strong-market-performance-3906176",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SMSPharmaceutic_valuationdot_3906176.png",
        "date": "2026-03-23 08:00:21",
        "description": "SMS Pharmaceuticals Ltd has witnessed a significant shift in its valuation parameters, moving from an expensive to a very expensive rating, driven by a surge in its price-to-earnings (P/E) and price-to-book value (P/BV) ratios. Despite this, the company’s stock has delivered exceptional returns over multiple time horizons, outperforming the broader Sensex by a wide margin."
      },
      {
        "title": "SMS Pharmaceuticals Ltd Surges 7.32% to Day's High of Rs 388.95 — Outperforms Sector by 4.45 Percentage Points",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sms-pharmaceuticals-ltd-hits-intraday-high-with-732-surge-on-20-mar-2026-3906533",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SMSPharmaceutic_priceRelatedfactors_3906533.png",
        "date": "2026-03-20 13:30:53",
        "description": "The Sensex advanced 1.03% on 20 Mar 2026, yet SMS Pharmaceuticals Ltd outpaced the broader market with a 7.32% gain, touching an intraday high of Rs 388.95. This 4.45-percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers highlights a distinctly stock-specific rally rather than a market-wide lift."
      },
      {
        "title": "SMS Pharmaceuticals Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sms-pharmaceuticals-ltd-is-rated-hold-3898650",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SMSPharmaceutic_mojoScore_3898650.png",
        "date": "2026-03-18 10:10:03",
        "description": "SMS Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, a rating that was last updated on 01 September 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 18 March 2026, providing investors with an up-to-date perspective on the company’s performance and outlook."
      },
      {
        "title": "SMS Pharmaceuticals Ltd: Valuation Shift Signals Price Attractiveness Amid Sector Dynamics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sms-pharmaceuticals-ltd-valuation-shift-signals-price-attractiveness-amid-sector-dynamics-3892596",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SMSPharmaceutic_valuationdot_3892596.png",
        "date": "2026-03-16 08:00:37",
        "description": "SMS Pharmaceuticals Ltd has witnessed a notable shift in its valuation parameters, moving from a very expensive to an expensive rating, reflecting evolving investor perceptions amid robust stock performance and sector dynamics. This article analyses the recent changes in key valuation metrics such as price-to-earnings (P/E) and price-to-book value (P/BV) ratios, comparing them with historical averages and peer benchmarks to assess the stock’s price attractiveness."
      },
      {
        "title": "SMS Pharmaceuticals Ltd Falls 2.21%: 4 Key Factors Driving This Week's Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sms-pharmaceuticals-ltd-falls-221-4-key-factors-driving-this-weeks-volatility-3891828",
        "imagepath": "",
        "date": "2026-03-14 17:21:50",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>Mar 2:</strong> Significant gap down opening amid market concerns</p>\n                    <p><strong>Mar 4:</strong> Moderate recovery with 1.19% gain despite Sensex decline</p>\n                    <p><strong>Mar 5:</strong> Strong rebound with 1.99% rise alongside Sensex gains</p>\n                    <p><strong>Mar 6:</strong> Week closes at Rs.375.70, down 2.21% for the week</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.384.20</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.375..."
      }
    ],
    "total": 744,
    "sid": "517655",
    "stock_news_url": "https://www.marketsmojo.com/news/sms-pharmaceuticals-517655"
  },
  "announcements": [
    {
      "caption": "Closure of Trading Window",
      "datetime": "25-Mar-2026",
      "details": "Closure of Trading Window for the quarter and year ended 31st March 2026.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "20-Mar-2026",
      "details": "Copy of Newspaper Publication",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Monitoring Agency Report",
      "datetime": "10-Feb-2026",
      "details": "Monitoring Agency Report for 31st Dec 2025",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "SMS Pharmaceuticals Ltd has declared <strong>40%</strong> dividend, ex-date: 22 Sep 25",
          "dt": "2025-09-22",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "SMS Pharmaceuticals Ltd has announced <strong>1:10</strong> stock split, ex-date: 17 Dec 15",
          "dt": "2015-12-17",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

SMS Pharmaceuticals Ltd Surges 7.38% to Day's High of Rs 389.8 — Outperforms Sector by 2.33 Percentage Points

2026-04-01 09:31:50

The Sensex advanced 2.66% on 1 Apr 2026, yet SMS Pharmaceuticals Ltd outpaced the broader market with a 7.38% gain, reaching an intraday high of Rs 389.8. This 2.33 percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers signals a distinctly stock-specific momentum shift.

Read full news article

SMS Pharmaceuticals Ltd is Rated Hold by MarketsMOJO

2026-03-29 10:10:02

SMS Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 01 September 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 March 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Read full news article

SMS Pharmaceuticals Gains 0.48%: 2 Key Factors Driving This Week’s Resilience

2026-03-28 15:08:38

Key Events This Week

23 Mar: Valuation shifts amid strong market performance

24 Mar: Intraday high with 7.82% surge

27 Mar: Week closes at Rs.386.55 (+0.48%)

Read full news article

SMS Pharmaceuticals Ltd Surges 7.82% to Day's High of Rs 397.3 — Outperforms Sector by 5.72 Percentage Points

2026-03-24 13:30:52

The Sensex advanced 2.26% on 24 Mar 2026, yet SMS Pharmaceuticals Ltd outpaced the broader market with a robust 7.82% gain, touching an intraday high of Rs 397.3. This 5.72-percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers signals a distinctly stock-specific momentum shift.

Read full news article

SMS Pharmaceuticals Ltd Valuation Shifts Amid Strong Market Performance

2026-03-23 08:00:21

SMS Pharmaceuticals Ltd has witnessed a significant shift in its valuation parameters, moving from an expensive to a very expensive rating, driven by a surge in its price-to-earnings (P/E) and price-to-book value (P/BV) ratios. Despite this, the company’s stock has delivered exceptional returns over multiple time horizons, outperforming the broader Sensex by a wide margin.

Read full news article

SMS Pharmaceuticals Ltd Surges 7.32% to Day's High of Rs 388.95 — Outperforms Sector by 4.45 Percentage Points

2026-03-20 13:30:53

The Sensex advanced 1.03% on 20 Mar 2026, yet SMS Pharmaceuticals Ltd outpaced the broader market with a 7.32% gain, touching an intraday high of Rs 388.95. This 4.45-percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers highlights a distinctly stock-specific rally rather than a market-wide lift.

Read full news article

SMS Pharmaceuticals Ltd is Rated Hold

2026-03-18 10:10:03

SMS Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, a rating that was last updated on 01 September 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 18 March 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Read full news article

SMS Pharmaceuticals Ltd: Valuation Shift Signals Price Attractiveness Amid Sector Dynamics

2026-03-16 08:00:37

SMS Pharmaceuticals Ltd has witnessed a notable shift in its valuation parameters, moving from a very expensive to an expensive rating, reflecting evolving investor perceptions amid robust stock performance and sector dynamics. This article analyses the recent changes in key valuation metrics such as price-to-earnings (P/E) and price-to-book value (P/BV) ratios, comparing them with historical averages and peer benchmarks to assess the stock’s price attractiveness.